Grant of options
Sagentia (AIM:SAG.L) announces that, in line with the management incentivisation strategy outlined in the Company's admission document published on 11 June 2008, it has, on 21/11/2008, granted various options over ordinary shares in its share capital, to directors and employees of the Company.
Options over 454,467 ordinary shares have been granted to directors of the Company as set out below, as a replacement for options granted under the Sagentia Group AG New Executive Share Option Scheme. As a result of this grant, and of the grant of similar options to non board level employees described below, the corresponding options granted under the Sagentia Group AG New Executive Share Option Scheme have been cancelled. Other Sagentia Group AG options, issued under the Sagentia Group AG Old Executive Share Option Scheme have become exercisable following the change of ownership in Sagentia Group AG but will expire at the end of December 2008. After 31/12/2008, no further options will be outstanding on the share capital of Sagentia Group AG. The Sagentia Group plc options are exercisable after two years from the date of grant of the original options granted under the Sagentia Group AG New Executive Share Option Scheme (the "Original Date of Grant") for a period of eight years at an exercise price of 1 Swiss Franc per share (to be converted into UK pence at the prevailing exchange rate at the time of exercise).
|
Director
|
No. of options
|
Original date of grant
|
|
Alistair Brown
|
147,079
|
24/12/2007
|
|
Alistair Brown
|
50,000
|
19/03/2008
|
|
Daniel Flicos
|
147,079
|
24/12/2007
|
|
Guy McCarthy
|
110,309
|
24/12/2007
|
In addition, options over a further 606,769 ordinary shares have been granted to directors of the Company under both the Sagentia Group plc Executive Share Option approved and unapproved schemes. These options are exercisable at an exercise price of 17.5 pence per share for a period of seven years from 21/11/2011.
|
Director
|
No. of options
|
|
Options granted under the approved scheme
|
|
Alistair Brown
|
171,428
|
|
Daniel Flicos
|
160,000
|
|
Guy McCarthy
|
171,428
|
|
Options granted under the approved scheme
|
|
Alistair Brown
|
78,572
|
|
Guy McCarthy
|
25,341
|
In addition, options over 1,503,250 ordinary shares, of which
- 522,365 are in replacement of options granted under the Sagentia Group AG New Executive Share Option Scheme and are exercisable at the UK£ equivalent of 1 Swiss Franc per share and
- 980,885 are exercisable at 17.5 pence per share,
have also been granted to other non board level employees.
Save for the above, the directors' beneficial interests in the share capital of the Company remain unchanged and as previously announced.
Enquiries:
| Sagentia Group plc & Sagentia Group AG |
Arbuthnot Securities |
Hansard Group |
| Alistair Brown; CEO |
John Prior |
Vikki Krause |
| Guy McCarthy; FD |
Antonio Bossi |
www.hansardgroup.co.uk
|
| +44 1223 875 200 |
+44 20 7012 2000 |
+44 20 7245 1100 |
About Sagentia
Sagentia is a leading international technology consulting and IP licensing organisation with a reputation for successfully commercialising emerging science and technology. Sagentia creates, develops and delivers business opportunities, products and services for its clients.
Established in 1986, Sagentia operates in six global market sectors - medical, industrial products, consumer products, chemicals, materials & energy, telecoms & media and public sector - developing new technologies, products and services that change the basis of competition. The company also assists business leaders to create strategies for technology, innovation and growth.
Sagentia has more than 200 employees and has resources situated in state-of-the-art facilities in Europe, the USA, and China. Sagentia is listed on AIM (SAG.L), the growth market of the London Stock Exchange.
www.sagentia.com/investors
investors@sagentia.com